SecBot SecBot
SECBOTREPLAY Home › Report › PCRX

PCRX · Royalty ruling reversed

Pacira BioSciences, Inc. · 8-K filed Nov 12, 2026 at 16:20 ET

At the news

BEARISHIMPACT 6/10

8-K filed Nov 12, 2026 at 16:20 ET

The Ninth Circuit reversed in part the District Court's judgment in Pacira's royalty dispute with RDF, ruling that Pacira owes royalties on EXPAREL made using its 200-liter manufacturing process. The case is remanded to recalculate pre-judgment interest on the 45-liter portion. Pacira had previously received a $28.3 million cash payment from RDF, which may now be partially at risk.

  • On November 6, 2026, the Ninth Circuit reversed the District Court's judgment in part, holding that Pacira owes royalties on EXPAREL manufactured using its 200-liter process.
  • The Court of Appeals directed the District Court to enter judgment in favor of RDF on the 200-liter claim.
  • The matter was remanded to recalculate pre-judgment interest RDF owes on the 45-liter EXPAREL portion.
  • Pacira had previously received a $28.3 million cash payment from RDF in July 2025, representing $23.1 million in royalties paid under protest plus $5.2 million in statutory interest.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access